DailyDoctor Archive Specialties Get app
Back to the 25 October 2026 edition

Clinical update · 01 of 05

Tranexamic acid at sleeve gastrectomy: less bleeding, no thrombotic signal

Worth considering preoperative tranexamic acid for sleeve gastrectomy, with thromboprophylaxis unchanged.

Design
Randomised, double-blind, placebo-controlled trial
Population
185 patients with severe obesity undergoing elective laparoscopic sleeve gastrectomy
Primary outcome
Perioperative bleeding and 24-hour haemoglobin
Effect
Intraoperative bleeding 1% vs 5.5% (p = 0.012); Hb 12.5 vs 11.1 g/dL

In this double-blind randomised trial, 185 patients with severe obesity undergoing elective laparoscopic sleeve gastrectomy received tranexamic acid or placebo before surgery.

Intraoperative bleeding was less frequent with tranexamic acid (1% vs 5.5%), and haemoglobin at 24 hours was higher (12.5 vs 11.1 g/dL). Transfusion requirements, haemodynamic stability and length of stay did not differ. No thromboembolic events occurred in either group.

The trial is small and single-country, and the absence of thrombosis in 93 treated patients cannot rule out a rare risk in a population already at high thrombotic risk. Staple-line bleeding is the commonest early complication of sleeve gastrectomy, so a cheap, familiar drug that reduces it is worth considering, alongside — not instead of — careful staple-line technique and standard thromboprophylaxis.

  • Consider a single preoperative dose of tranexamic acid for laparoscopic sleeve gastrectomy.
  • Keep standard mechanical and pharmacological thromboprophylaxis in place.
  • Exclude patients with prior venous thromboembolism or other contraindications to tranexamic acid.
  • Transfusion rates did not fall in this trial, so the benefit is fewer bleeds rather than fewer units given.

Why it matters

Staple-line bleeding is the commonest early problem after sleeve gastrectomy, and this targets it with an inexpensive drug.

Don't overread it

Too small to establish thrombotic safety in a high-risk bariatric population.

The statistics, in plain English

Bleeding fell from about 1 in 18 patients to about 1 in 100. With only 185 patients, the trial was too small to detect a rare increase in thrombosis, so 'no events' is reassuring but not proof of safety.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

uppergimiscolorectalsurgcomp

Tomorrow morning, before your first patient

One edition a day for general surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app